SCHEMBL1026192

SCHEMBL1026192

CC1=C(C(C)C)C=CC(=O)C1

nearest known ligand 0.43

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
GSK3A P49840 1/20 0.43
GSK3B P49841 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16572713 0.72
SCHEMBL9743740 0.67
SCHEMBL277815 0.64
SCHEMBL17581123 0.64
SCHEMBL714797 0.64
SCHEMBL8093009 0.64
SCHEMBL13228776 0.60
SCHEMBL366153 0.59 GSK3A (0.71) GSK3AGSK3B
SCHEMBL10780747 0.59 GSK3A (0.43) GSK3AGSK3B
SCHEMBL12130383 0.59

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112198220-B Gas sensor and method of sensing a gas phase analyte 杜邦电子材料国际有限责任公司 2025-05-09 CN disclosed
CN-114106275-B Underlayer composition and patterning process 杜邦电子材料国际有限责任公司 2025-04-25 CN disclosed
WO-2025066019-A1 TOPICAL DELIVERY COMPOSITIONS COMPRISING NON-STEROIDAL ANTI-INFLAMMATORY DRUGS ANDROS PHARMACEUTICALS CO., LTD. (CN) 2025-04-03 WO disclosed
EP-4529917-A1 TOPICAL DELIVERY COMPOSITIONS COMPRISING NON-STEROIDAL ANTI-INLAMMATORY DRUGS Andros Pharmaceuticals Co., Ltd. (TW) 2025-04-02 EP disclosed
US-20250099369-A1 TOPICAL DELIVERY COMPOSITIONS COMPRISING NON-STEROIDAL ANTI-INFLAMMATORY DRUGS ANDROS PHARMACEUTICALS CO., LTD. (TW) 2025-03-27 US disclosed
CN-112285998-B Method for forming pattern using antireflective coating composition comprising photoacid generator 罗门哈斯电子材料有限责任公司 2025-01-03 CN disclosed
CN-112015049-B Resist underlayer composition and pattern forming method using the same 罗门哈斯电子材料有限责任公司 2024-08-30 CN disclosed
CN-113126432-B For photoresists primer coating composition 罗门哈斯电子材料韩国有限公司 2024-08-23 CN disclosed
CN-118541011-A Polymer material for piezoelectric device 株式会社大阪曹达 2024-08-23 CN disclosed
CN-118475859-A Liquid crystal composition, cured product, optically anisotropic layer, optical element, and light guide element 富士胶片株式会社 2024-08-09 CN disclosed
US-6495159-B2 FOR ADMINISTERING A VOMITING DEPRESSANT AT THE TIME OF CHEMOTHERAPY OF CANCER; DRUG DELIVERY HISAMITSU PHARMACEUTICAL CO., INC. (JP) 2002-12-17 US disclosed
EP-0651993-B1 PERCUTANEOUSLY ADMINISTRABLE BASE COMPOSITION AND DRUG COMPOSITION PREPARED THEREFROM HISAMITSU PHARMACEUTICAL CO (JP) 2002-10-09 EP disclosed
EP-0757910-B1 PERCUTANEOUSLY ADMINISTRABLE BASE COMPOSITION AND PERCUTANEOUSLY ADMINISTRABLE DRUG COMPOSITION PREPARED THEREFROM HISAMITSU PHARMACEUTICAL CO (JP) 2002-09-11 EP disclosed
US-20020102290-A1 TRANSDERMAL PREPARATION CONTAINING SEROTONIN RECEPTOR ANTAGONIST HISAMITZU PHARMACEUTICAL CO., INC. (JP) 2002-08-01 US disclosed
EP-0993829-A1 TRANSDERMAL PREPARATION CONTAINING SEROTONIN RECEPTOR ANTAGONIST HISAMITSU PHARMACEUTICAL CO., INC. (JP) 2000-04-19 EP disclosed
US-5932227-A 10% LOWER ALCOHOL, 10-50 % HUMECTANT, 10-70 % WATER, 0.1-15 % ABIRRITANT, 0.1-15 % ABSORPTION PROMOTER HISAMITSU PHARMACEUTICAL CO., INC. (JP) 1999-08-03 US disclosed
US-5733900-A GASTROINTESTINAL DISORDERS HISAMITSU PHARMACEUTICAL CO., INC. (JP) 1998-03-31 US disclosed
EP-0757910-A1 PERCUTANEOUSLY ADMINISTRABLE BASE COMPOSITION AND PERCUTANEOUSLY ADMINISTRABLE DRUG COMPOSITION PREPARED THEREFROM Hisamitsu Pharmaceutical Co., Inc. (JP) 1997-02-12 EP disclosed
EP-0651993-A1 PERCUTANEOUSLY ADMINISTRABLE BASE COMPOSITION AND DRUG COMPOSITION PREPARED THEREFROM Hisamitsu Pharmaceutical Co., Inc. (JP) 1995-05-10 EP disclosed
EP-0535237-A1 COMPOSITION FOR RELIEVING SKIN IRRITATION AND EXTERNAL PREPARATION FOR PERCUTANEOUS ADMINSTRATION CONTAINING THE SAME Hisamitsu Pharmaceutical Co., Inc. (JP) 1993-04-07 EP disclosed